Acyclovir
- Product NDC
- 82804-005
- 11-digit product format
- 828040005
- Labeler code
- 82804
- Product ID
- 82804-005_2ff9056b-ed65-4a2b-abb1-793b1fe9bf4c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acyclovir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Proficient Rx LP
- Application
- ANDA210401
- Marketing category
- ANDA
- Marketing start
- 2023-06-20
- Substance
- ACYCLOVIR
- Active strength
- 400 mg/1
- Pharmacologic classes
- DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| X4HES1O11F | ACYCLOVIR | 59277-89-3 | ACYCLOVIR |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 82804-005-06 | 82804000506 | 6 TABLET in 1 BOTTLE (82804-005-06) | 6 tablet | 2024-01-09 | No | No | Historical |
| 82804-005-15 | 82804000515 | 15 TABLET in 1 BOTTLE (82804-005-15) | 15 tablet | 2024-01-09 | No | No | Historical |
| 82804-005-20 | 82804000520 | 20 TABLET in 1 BOTTLE (82804-005-20) | 20 tablet | 2024-01-09 | No | No | Historical |
| 82804-005-21 | 82804000521 | 21 TABLET in 1 BOTTLE (82804-005-21) | 21 tablet | 2024-01-09 | No | No | Historical |
| 82804-005-30 | 82804000530 | 30 TABLET in 1 BOTTLE (82804-005-30) | 30 tablet | 2023-08-31 | No | No | Historical |
| 82804-005-35 | 82804000535 | 35 TABLET in 1 BOTTLE (82804-005-35) | 35 tablet | 2024-01-09 | No | No | Historical |
| 82804-005-60 | 82804000560 | 60 TABLET in 1 BOTTLE (82804-005-60) | 60 tablet | 2023-08-31 | No | No | Historical |
| 82804-005-90 | 82804000590 | 90 TABLET in 1 BOTTLE (82804-005-90) | 90 tablet | 2023-08-31 | No | No | Historical |